Cited 3 times in
Contraception in the COVID-19 pandemic: recommendations from the Korean society of contraception and reproductive health
DC Field | Value | Language |
---|---|---|
dc.contributor.author | 이재훈 | - |
dc.date.accessioned | 2022-12-22T01:34:04Z | - |
dc.date.available | 2022-12-22T01:34:04Z | - |
dc.date.issued | 2022-03 | - |
dc.identifier.issn | 2287-8572 | - |
dc.identifier.uri | https://ir.ymlib.yonsei.ac.kr/handle/22282913/191259 | - |
dc.description.abstract | Coronavirus disease 2019 (COVID-19) is associated with a systemic inflammatory response that activates coagulation in symptomatic patients. In addition, a rare form of thrombosis has been reported in people who received the COVID-19 vaccine, most of whom were women younger than 50 years of age. Considering that hormonal contraceptive methods widely used by women of childbearing age increase the risk of thrombosis, the development of guidelines for the use of hormonal contraceptives in the era of the COVID-19 pandemic is necessary. In this context, the Korean Society of Contraception and Reproductive Health provides guidelines for issues regarding contraception and reproductive health during the pandemic. | - |
dc.description.statementOfResponsibility | open | - |
dc.language | English | - |
dc.publisher | Korean Society of Obstetrics and Gynecology | - |
dc.relation.isPartOf | Obstetrics & Gynecology Science | - |
dc.rights | CC BY-NC-ND 2.0 KR | - |
dc.title | Contraception in the COVID-19 pandemic: recommendations from the Korean society of contraception and reproductive health | - |
dc.type | Article | - |
dc.contributor.college | College of Medicine (의과대학) | - |
dc.contributor.department | Dept. of Obstetrics and Gynecology (산부인과학교실) | - |
dc.contributor.googleauthor | Jae Hoon Lee | - |
dc.contributor.googleauthor | Jae Yen Song | - |
dc.contributor.googleauthor | Kyong Wook Yi | - |
dc.contributor.googleauthor | Jin Ju Kim | - |
dc.contributor.googleauthor | Kyu Ri Hwang | - |
dc.contributor.googleauthor | Jung-Ho Shin | - |
dc.contributor.googleauthor | Ji Young Lee | - |
dc.contributor.googleauthor | Hee Dong Chae | - |
dc.identifier.doi | 10.5468/ogs.21322 | - |
dc.contributor.localId | A04636 | - |
dc.relation.journalcode | J02408 | - |
dc.identifier.eissn | 2287-8580 | - |
dc.identifier.pmid | 35081676 | - |
dc.subject.keyword | COVID-19 | - |
dc.subject.keyword | COVID-19 vaccines | - |
dc.subject.keyword | Contraception | - |
dc.subject.keyword | Contraceptives, oral, combined | - |
dc.subject.keyword | Long-acting reversible contraception | - |
dc.contributor.alternativeName | Lee, Jae Hoon | - |
dc.contributor.affiliatedAuthor | 이재훈 | - |
dc.citation.volume | 65 | - |
dc.citation.number | 2 | - |
dc.citation.startPage | 125 | - |
dc.citation.endPage | 132 | - |
dc.identifier.bibliographicCitation | Obstetrics & Gynecology Science, Vol.65(2) : 125-132, 2022-03 | - |
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.